Skip to main content
. 2018 Mar 12;47(3):928–937. doi: 10.1093/ije/dyy032

Table 2.

Characteristics of participants included in this study (AFAST offspring, N = 86)

Variable Category Placebo (n = 43) Folic-acid supplement
0.2 mg/day (n = 20) 5 mg/day (n = 23)
Categorical n (%) n (%) n (%) Chi2
 Age at follow-up (years) (N = 86) 46 6 (14.0) 14 (70.0) 6 (26.1)
47 33 (76.7) 6 (30.0) 17 (73.9)
48 4 (9.3) <0.001
 Current smoking (N = 86) No 26 (60.5) 9 (45) 14 (60.9)
Yes 17 (39.5) 11 (55) 9 (39.1) 0.47
 Education (N = 84) ≤O-level 19 (46.3) 10 (50) 12 (52.2)
A-level/university 22 (53.7) 10 (50) 11 (47.8) 0.90
 Alcohol intake Daily/weekly 19 (44.2) 12 (60.0) 12 (52.2) 0.56
Monthly 20 (46.5) 8 (40.0) 10 (43.5)
Not at all 4 (9.30) 0 (0) 1 (4.4)
 Folic-acid supplements Yes 1 (2.3) 1 (5.0) 0 (0)
No 42 (97.7) 19 (95.0) 23 (100) 0.56
 Current medication Yes 31 (72.1) 15 (75.0) 17 (73.9) 0.97
No 12 (27.9) 5 (25.0) 6 (26.1)
 Health problems Yes 25 (58.1) 12 (60.0) 14 (60.9) 0.98
No 18 (41.9) 8 (40.0) 9 (39.1)
Continuous Mean (SD) Mean (SD) Mean (SD) ANOVA
 BMI (kg/m2) (N = 85) 24.2 (3.8) 26.5 (6.4) 27.8 (7.2) 0.04
 Length of gestation (weeks) (N = 86) 40.9 (1.1) 39.9 (2.6) 40.3 (1.5) 0.07
 Birthweight (g) (N = 86) 3333 (506) 3093 (620) 3269 (493) 0.25